IndraLab

Statements


| 1

reach
"Besides, LY411575 treatment also increased the percentage of PGP9.5 + cells by 2.5 +/- 0.6 fold (p < 0.05, Figure XREF_FIG F-G), while 616452 drastically decreased the ratio of PGP9.5 + cells by 61 +/- 19% compared to NWR control (p < 0.05, Figure XREF_FIG F-G)."